Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Financial Results
    • Sanofi India June...

    Sanofi India June quarter net profit up 35 percent to Rs 99.6 crore

    Written by Ruby Khatun Khatun Published On 2018-07-29T10:30:31+05:30  |  Updated On 29 July 2018 10:30 AM IST
    Sanofi India June quarter net profit up 35 percent to Rs 99.6 crore

    New Delhi: Drug firm Sanofi India reported a 35.14 percent rise in its net profit to Rs 99.6 crore for the second quarter ended June 30, 2018.


    The company had posted a net profit of Rs 73.7 crore for the corresponding period of the previous fiscal, Sanofi India said in a filing to the BSE.


    Total revenue from operations rose to Rs 683.6 crore for the quarter under consideration as compared to Rs 600.6 crore for the same period a year ago.


    The board of directors of the company has declared an interim dividend of Rs 18 per equity share of Rs 10 each for the financial year ending December 31, 2018, Sanofi India said.


    In a separate filing, the company said its board has also approved the appointment of Charles Billard as whole time director for a period of 5 years with effect from July 25, 2018.


    The company said Lionel Guerin has tendered resignation as non-executive director of the company as he would be relocating outside of India to take up a new role within Sanofi Group.

    appointmentboard of directorsCharles BillardFinancial resultsinterim dividendJune quarterLionel Guerinnet profitnon-executive directorresignationrevenueSanofiSanofi Indiawhole-time director
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok